Sarah Hallberg, DO, MS, ACSM-CEP, FOMA, FNLA, previews her presentation “Dietary Fat as a Cause of Metabolic Disease,” which begins at 11:30 a.m. CT Friday, June 12.
Five experts will review critical lessons from two decades of surveillance and observational research into youth-onset diabetes during a two-hour virtual symposium at the Scientific Sessions. The expert presenters, including symposium chair Dana Dabelea, MD, PhD, are key participants in the SEARCH for Diabetes in Youth Study, a national multi-center study with centers in California,…
Corporate Symposia are programs that are planned and conducted by the corporate community in conjunction with the Virtual 80th Scientific Sessions to provide attendees with additional educational opportunities. There are currently 10 Corporate Symposia scheduled beginning Friday, June 12.
Eran Segal, PhD, previews his presentation “Efficacy of Personalized Nutrition Based on Gut Microbiome and Clinical Data in Prediabetes,” which begins at 11:40 a.m. CT Saturday, June 13.
Guoxun Chen, PhD, previews his response and discussion from the Professional Interest Group Discussion “Nutritional Science and Metabolism—Emerging Methodologies for Personalized Nutrition—Potential Effects on Glycemic and Other Diabetes-Related Outcomes?” The session begins at 11:30 a.m. CT Saturday, June 13. Dr. Chen’s presentation will begin at 12:10 p.m. CT.
Emma E. Hamilton-Williams, PhD, describes results from the TOGeTHER Trial of type 1 diabetes patients, who were treated with a specially modified dietary fiber designed to deliver short-chain fatty acids into the large intestine. Her presentation details the impact of the supplement on the gut bacteria and diabetes management of the participants, revealing a promising…
Jessica L. Turton, APD, BAppSc (Ex&SpSc), MNutriDiet, previews her presentation “Low-Carbohydrate Diets and Nutritional Ketosis,” which begins at 2:30 p.m. CT Friday, June 12.
Gretchen Benson, RDN, CDCES, discussed how a team-based approach featuring an expanded role for registered dietitian nutritionists (RDN) can help patients with type 2 diabetes, hypertension, and hyperlipidemia achieve better outcomes. She highlighted results from several studies demonstrating the benefits of expanding the role of RDNs in initiating/titrating medications.
ADA’s Interest Group Leadership Teams have been hard at work planning virtual networking events, which will allow members to linger virtually at the back of the lecture hall discussing new research, share perspectives on a variety of hot topics in diabetes, and contribute to the future planning of ADA’s Interest Group activities.
A panel of investigators, including Beena Akolkar, PhD, will present recent findings from the ongoing TEDDY Study during the Scientific Sessions. TEDDY is a multi-center study funded by the NIDDK designed to investigate the etiology of type 1 diabetes and identify environmental triggers of the disease.